CME webinar series: Empowering Providers on Substance Use Disorders

Jun. 2025Education/Webinars

Register for our new CME webinar series: Empowering Providers on Substance Use Disorders

Join us for our upcoming CME webinar series, "Empowering Providers," designed to enhance your knowledge and skills in managing substance use disorders. This four-part series will provide you with the latest insights and evidence-based strategies to improve patient outcomes.

Overdose Prevention and Response Training

  • Join us on Aug. 26, 2025, from noon to 1 p.m., to learn how to recognize overdose risks and symptoms, respond effectively, and apply proven strategies to prevent patient overdose.

    Comprehensive Care for Alcohol Use Disorder

  • Join us on Sept. 9, 2025, from noon to 1 p.m., to explore the importance of screening for alcohol use disorder (AUD), learn how to use effective screening tools, and apply evidence-based treatment strategies to improve patient care.

    Comprehensive Care for Opioid Use Disorder

  • Join us on Sept. 30, 2025, from noon to 1 p.m., to explore the importance of screening for opioid use disorder (OUD), learn how to use effective screening tools, and implement evidence-based treatments to support recovery.

    Comprehensive Care for Tobacco Use Disorder

  • Join us on Nov. 12, 2025, from noon to 1 p.m., to learn how to recognize tobacco use disorder (TUD), use proven screening tools, and deliver evidence-based care to help patients quit tobacco successfully.

Register Now

Provider is responsible for verifying CME eligibility.

This activity is approved for the following credit: AMA PRA Category 1 Credit™, ANCC, ACPE, and ASWB. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.


Recent Announcements

Voluntary nationwide recall: Cyclobenzaprine (Unichem – August 2025)

Unichem Pharmaceuticals (USA), Inc. is recalling one lot, lot GMML24026A, of Cyclobenzaprine Hydrochloride Tablets USP 10 mg. Cyclobenzaprine is used for the relief of muscle spasms from certain conditions.
Sep. 2025Pharmacy Updates

Voluntary nationwide recall: Lactated Ringers and 0.9% Sodium Chloride (B. Braun-Aug)

B. Braun Medical, Inc. is recalling two lots of Lactated Ringers Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL. These are intravenous (IV) fluids commonly used in the hospital to treat dehydration and other conditions.
Aug. 2025Pharmacy Updates

CME Webinar: Evaluating Antimicrobial Stewardship Techniques in the Outpatient Setting

Please join us for a live, CME-accredited webinar on Tuesday, Nov. 4, from noon to 1 p.m. that will share an overview of evaluating antimicrobial stewardship techniques in the outpatient setting.
Aug. 2025Education/Webinars